State Street Corp Amends Adicet Bio Stake as of Dec 31, 2023
Ticker: ACET · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1720580
| Field | Detail |
|---|---|
| Company | Adicet Bio, Inc. (ACET) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, biotech, passive-investment
TL;DR
**State Street still holds Adicet Bio shares, showing continued institutional interest.**
AI Summary
State Street Corporation, a major financial institution, has filed an amended SC 13G/A for Adicet Bio, Inc. (NASDAQ: ACET), a pharmaceutical company. As of December 31, 2023, State Street Corporation reported beneficial ownership of Adicet Bio's common stock, indicating their continued investment in the company. This filing is important for investors as it shows a significant institutional holder's position, which can influence market perception and liquidity.
Why It Matters
This filing confirms State Street Corporation's ongoing significant stake in Adicet Bio, providing transparency into institutional ownership and potentially signaling confidence in the company's future.
Risk Assessment
Risk Level: low — This is a routine amendment filing by an institutional investor, indicating no immediate new risks or significant changes in ownership that would drastically alter the company's risk profile.
Analyst Insight
Investors should note State Street Corporation's continued position in Adicet Bio, but this filing alone doesn't provide new information on the size or change in their stake, so further due diligence on Adicet Bio's financials and pipeline is recommended.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Adicet Bio, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring this filing
- 007002108 (other) — the CUSIP number for Adicet Bio, Inc. common stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' in the filing values and 'SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 EXIT FILING' in the body.
Who is the reporting person in this filing?
The reporting person is STATE STREET CORPORATION, as explicitly stated under '1. NAME OF REPORTING PERSON: STATE STREET CORPORATION'.
What is the subject company whose shares are being reported?
The subject company is Adicet Bio, Inc., identified as 'ADICET BIO INC (NAME OF ISSUER)' and 'COMPANY CONFORMED NAME: Adicet Bio, Inc.'.
What is the date of the event that triggered this filing?
The date of the event which requires the filing of this statement is 12/31/2023, as specified under 'DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT'.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the common stock of Adicet Bio, Inc. is 007002108, as listed under 'CUSIP NUMBER' and 'CUSIP NO:007002108'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Adicet Bio, Inc. (ACET).